ALS Association Seed Grants
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- _ You can learn more about this opportunity by visiting the funder's [website](https://www.als.org/sites/default/files/2023-05/Seed-Grant-RFA-2023-2.pdf).
Not eligible / not funded
- Not eligible: Please note: This funding opportunity will not support clinical trials, preclinical drug development activities (e.g., pharmacokinetics, pharmacodynamics, and safety and toxicology studies), or early drug development studies (e.g., hit-to-lead and lead optimization).
Overview
_NOTE: At this time, we have paused the launch of new requests for applications as we seek to better understand the impact of recent changes to the research funding landscape and work with our Research Committee to prioritize future funding opportunities._
The ALS Association is the largest philanthropic funder of ALS research worldwide. Through our global research program, we are at the forefront of efforts to find new treatments and a cure for ALS in addition to making life better for people currently living with the disease, their caregivers, and their families. Association-funded grants and awards have led to some of the most promising and significant advances in ALS research.
Through its Seed Grants, the Association seeks to fund research with a strong scientific rationale and potential for significant impact in ALS but limited preliminary data. These one-year awards with a maximum budget of $50,000 should be used to gather preliminary data that will support future applications to larger grant award programs.
Topics of Interest (Scope)
We will accept applications from all scientific disciplines on topics that have the potential to ultimately transform the experience of ALS by optimizing the care and treatments we have, finding new treatments and cures, and/or preventing ALS. In addition to projects focused on ALS, projects that investigate the continuum of disease spanning ALS and frontotemporal dementia (FTD) are also in scope.
- Drug target identification
- Biomarkers
- Prevention
- Clinical tools and techniques
- Big data approaches
- Assistive technology
- Studies that document and reduce the harms of ALS on caregivers and families of people living with the disease
- Any other proposal with the potential to significantly improve the lives of those impacted by ALS
Please note: This funding opportunity will not support clinical trials, preclinical drug development activities (e.g., pharmacokinetics, pharmacodynamics, and safety and toxicology studies), or early drug development studies (e.g., hit-to-lead and lead optimization).
Eligibility
_ You can learn more about this opportunity by visiting the funder's website.
What Amyotrophic Lateral Sclerosis Assn actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 185
- Total given
- $11.87M
- Median grant
- $25K
- Range
- $5,126–$652K
- By dollars: Florida 22%, California 12%, Minnesota 9%. Top recipient cities: Los Angeles, CA; Chicago, IL; New York, NY.
- 0% of grants with a stated purpose were for general or operating support.
- 19% of recipients were new grantees, not repeat recipients.
Example grants
University of Miami · Miami, FL
Bitner plante quarterly grant fy25
$652K
University Medical Service Association Inc · Orlando, FL
Bitner plante quarterly grant fy25
$551K
Mayo Clinic Florida · Rochester, MN
Bitner plante quarterly grant fy25
$426K
American Brain Foundation · Minneapolis, MN
Clinical scientist development award/clinical research training fellowship/shelia…
$323K
Asha Therapeutics · Tampa, FL
Drug development contract
$250K
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Rare Disease Endpoint Advancement Pilot Program Grant
Amyotrophic Lateral Sclerosis Assn
Amount
Varies
Deadline
Deadline not published
Seed Grants
Amyotrophic Lateral Sclerosis Assn
Amount
Varies
Deadline
Deadline not published
Hoffman ALS Clinical Trial Awards Program
Amyotrophic Lateral Sclerosis Assn
Amount
Varies
Deadline
Deadline not published
Milton Safenowitz Postdoctoral Fellowship Program
Amyotrophic Lateral Sclerosis Assn
Amount
Varies
Deadline
Deadline not published
Frontiers Planet Prize to Accelerate Scientific Solutions for Healthy Lives on a Healthy Planet
National Academy of Sciences
Amount
Varies
Deadline
Expected ~October
Based on past cycles
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $50,000
Deadline
October 19, 2026
Ready to apply for ALS Association Seed Grants?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found ALS Association Seed Grants. Now let's win it.